Northwestern Medicine scientists Ramon Lorenzo-Redondo, Ph.D., and Egon Ozer, MD, Ph.D., recently flew into the airport in Iquitos, a remote Peruvian city in the depths of the Amazon jungle accessible only by plane or river ...
Jul 29, 2022
0
2
The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which expanded to conduct research into COVID-19, today announced the publication of "Monoclonal Antibody Treatment Drives Rapid Culture Conversion ...
Jul 26, 2022
0
5
People who supplement rescue inhalers with a second asthma medication sometimes get little relief at first, but there's good news: Those who keep trying different options often find a medication that works, according to Rutgers ...
Jul 22, 2022
0
5
Researchers have called for an experimental COVID treatment, which has shown early indications of being more effective against dominant Omicron subvariants, to be made available outside the United States.
Jul 22, 2022
0
14
Australia is currently in its third omicron wave (second if you live in Western Australia). This one is caused by the subvariants BA.4 and BA.5.
Jul 20, 2022
0
4
A monoclonal antibody treatment taken by patients hospitalized with COVID-19 did not improve recovery time but did reduce deaths, according to a study published July 8 in The Lancet Respiratory Medicine.
Jul 11, 2022
0
139
Army scientists and industry partners were among the first to demonstrate that messenger RNA (mRNA)—the technology recently used in COVID-19 vaccines and others—could also be used to develop treatments for infectious ...
Jul 6, 2022
0
48
Last year, pathologist Jeffrey SoRelle, M.D., and colleagues developed CoVarScan, a rapid COVID-19 test that detects the signatures of eight hotspots on the SARS-CoV-2 virus. Now, after testing CoVarScan on more than 4,000 ...
Jul 3, 2022
0
175
A study of 10,775 high-risk adult patients during the COVID-19 delta variant surge in late 2021 finds that treatment with one of three anti-spike neutralizing monoclonal antibodies for mild to moderate symptoms led to low ...
Jun 27, 2022
0
75
Two broadly neutralizing antibodies show great promise to provide long-acting immunity against COVID-19 in immunocompromised populations according to a paper published June 15 in the Journal of Experimental Medicine (JEM). ...
Jun 15, 2022
0
5
